Kestra Medical Technologies (KMTS) Change in Receivables (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Change in Receivables data on file, last reported at $2.7 million in Q1 2026.

• Quarterly Change in Receivables fell 20.42% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $7.1 million (down 20.3% YoY) and the FY2025 annual result came in at $8.8 million, up 251.36% from the prior year.
• Change in Receivables improved to $2.7 million in Q1 2026 per KMTS's latest filing, from $1.7 million in the prior quarter.
• Across five years, Change in Receivables topped out at $3.3 million in Q1 2025 and bottomed at $963000.0 in Q2 2025.
• The 3-year median for Change in Receivables is $1.7 million (2025), against an average of $2.0 million.
• Peak annual rise in Change in Receivables reached 7.91% in 2025, while the deepest fall reached 38.51% in 2025.
• Tracing KMTS's Change in Receivables over 3 years: stood at $1.6 million in 2024, then increased by 7.91% to $1.7 million in 2025, then soared by 56.07% to $2.7 million in 2026.
• Per Business Quant, the three latest KMTS Change in Receivables figures stand at $2.7 million (Q1 2026), $1.7 million (Q4 2025), and $1.8 million (Q3 2025).

Peer Comparison